The medical world is seeing a significant shift in diabetes treatment with the arrival of GLP-1 transdermal devices. These devices offer a seemingly more comfortable alternative to subcutaneous administrations of GLP-1 receptor agonists, reducing the requirement of daily needle sticks. The approa